Investigating non-transplanted patients presenting in the emergency room with laboratory-confirmed COVID-19, of whom one-third developed AKI, the levels of NGAL showed a good performance for predicting AKI (AUC = 0.81) and a need for RRT (AUC = 0.87) [36]. This evidence concerns the gene LCN2 and COVID-19.